The Effect of n-3 Fatty Acids on Heart Rate Variability in Patients Treated With Chronic Hemodialysis

Journal of Renal Nutrition

Volumn 17, Issue 4, 2007, Pages 243-249

  Svensson, My ^a   Schmidt, Erik B ^a   Jørgensen, Kaj A ^b   Christensen, Jeppe H ^a  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

OMEGA 3 FATTY ACID; PHOSPHOLIPID;

AGED; ARTICLE; BLOOD; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HUMAN; MALE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY;

AGED; CARDIOVASCULAR DISEASES; DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY, AMBULATORY; FATTY ACIDS, OMEGA-3; FEMALE; HEART RATE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PHOSPHOLIPIDS; RENAL DIALYSIS;

EID: 34250681718     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2007.02.004     Document Type: Article

References (44)

1. Sarnak M.J., Levey A.S., Schoolwerth A.C., et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 108 (2003) 2154-2169
2. US Renal Data System: USRDS 2004 Annual Data Report. Atlas of end-stage renal disease in the United States (2005), National Institutes of Health, National Institutes of Diabetes and Kidney Diseases, Bethesda, MD
3. Herzog C.A. Sudden cardiac death and acute myocardial infarction in dialysis patients: perspectives of a cardiologist. Semin Nephrol 25 (2005) 363-366
4. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation 93 (1996) 1043-1065
5. Kurata C., Uehara A., Sugi T., et al. Cardiac autonomic neuropathy in patients with chronic renal failure on hemodialysis. Nephron 84 (2000) 312-319
6. Robinson T.G., and Carr S.J. Cardiovascular autonomic dysfunction in uremia. Kidney Int 62 (2002) 1921-1932
7. Joles J.A., and Koomans H.A. Causes and consequences of increased sympathetic activity in renal disease. Hypertension 43 (2004) 699-706
8. Tsuji H., Larson M.G., Venditti Jr. F.J., et al. Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study. Circulation 94 (1996) 2850-2855
9. La Rovere M.T., Bigger Jr. J.T., Marcus F.I., Mortara A., Schwartz P.J., and ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. Lancet 351 (1998) 478-484
10. Fukuta H., Hayano J., Ishihara S., et al. Prognostic value of heart rate variability in patients with end-stage renal disease on chronic haemodialysis. Nephrol Dial Transplant 18 (2003) 318-325
11. Hayano J., Takahashi H., Toriyama T., et al. Prognostic value of heart rate variability during long-term follow-up in chronic haemodialysis patients with end-stage renal disease. Nephrol Dial Transplant 14 (1999) 1480-1488
12. Leaf A., Kang J.X., Xiao Y.F., and Billman G.E. Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils. Circulation 107 (2003) 2646-2652
13. Matthan N.R., Jordan H., Chung M., Lichtenstein A.H., Lathrop D.A., and Lau J. A systematic review and meta-analysis of the impact of omega-3 fatty acids on selected arrhythmia outcomes in animal models. Metabolism 54 (2005) 1557-1565
14. Xiao Y.F., Sigg D.C., and Leaf A. The antiarrhythmic effect of n-3 polyunsaturated fatty acids: modulation of cardiac ion channels as a potential mechanism. J Membr Biol 206 (2005) 141-154
15. Dallongeville J., Yarnell J., Ducimetiere P., et al. Fish consumption is associated with lower heart rates. Circulation 108 (2003) 820-825
16. Mozaffarian D., Geelen A., Brouwer I.A., Geleijnse J.M., Zock P.L., and Katan M.B. Effect of fish oil on heart rate in humans: a meta-analysis of randomized controlled trials. Circulation 112 (2005) 1945-1952
17. Christensen J.H. n-3 fatty acids and the risk of sudden cardiac death. Emphasis on heart rate variability. Dan Med Bull 50 (2003) 347-367
18. Siscovick D.S., Raghunathan T., King I., et al. Dietary intake of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. Am J Clin Nutr 71 (2000) 208S-212S
19. Albert C.M., Campos H., Stampfer M.J., et al. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 346 (2002) 1113-1118
20. Marchioli R., Barzi F., Bomba E., et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 105 (2002) 1897-1903
21. Friedman A., and Moe S. Review of the effects of omega-3 supplementation in dialysis patients. Clin J Am Soc Nephrol (2006) 182-192
22. Svensson M., Schmidt E.B., Jørgensen K.A., and Christensen J.H. n-3 fatty acids as secondary prevention against cardiovascular events in patients treated with chronic hemodialysis: a randomised, placebo controlled intervention trial. Clin J Am Soc Nephrol 1 (2006) 780-786
23. Cashion A.K., Cowan P.A., Milstead E.J., Gaber A.O., and Hathaway D.K. Heart rate variability, mortality, and exercise in patients with end-stage renal disease. Prog Transplant 10 (2000) 10-16
24. Yildiz A., Sever M.S., Demirel S., et al. Improvement of uremic autonomic dysfunction after renal transplantation: a heart rate variability study. Nephron 80 (1998) 57-60
25. Christensen J.H., Aaroe J., Knudsen N., et al. Heart rate variability and n-3 fatty acids in patients with chronic renal failure-a pilot study. Clin Nephrol 49 (1998) 102-106
26. Nishimura M., Hashimoto T., Kobayashi H., et al. Association between cardiovascular autonomic neuropathy and left ventricular hypertrophy in diabetic haemodialysis patients. Nephrol Dial Transplant 19 (2004) 2532-2538
27. Coquet I., Mousson C., Rifle G., et al. Influence of ischemia on heart-rate variability in chronic hemodialysis patients. Ren Fail 27 (2005) 7-12
28. Freemantle N., Cleland J., Young P., Mason J., and Harrison J. Beta blockade after myocardial infarction: systematic review and meta regression analysis. BMJ 318 (1999) 1730-1737
29. Brophy J.M., Joseph L., and Rouleau J.L. Beta-blockers in congestive heart failure. A Bayesian meta-analysis. Ann Intern Med 134 (2001) 550-560
30. Abbott K.C., Trespalacios F.C., Agodoa L.Y., Taylor A.J., and Bakris G.L. Beta-blocker use in long-term dialysis patients: association with hospitalized heart failure and mortality. Arch Intern Med 164 (2004) 2465-2471
31. Ezekowitz J., McAlister F.A., Humphries K.H., et al. The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease. J Am Coll Cardiol 44 (2004) 1587-1592
32. Cice G., Ferrara L., D'Andrea A., et al. Carvedilol increases two-year survival in dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial. J Am Coll Cardiol 41 (2003) 1438-1444
33. Tory K., Horvath E., Suveges Z., et al. Effect of propranolol on heart rate variability in patients with end-stage renal disease: a double-blind, placebo-controlled, randomized crossover pilot trial. Clin Nephrol 61 (2004) 316-323
34. Rubinger D., Sapoznikov D., Pollak A., Popovtzer M.M., and Luria M.H. Heart rate variability during chronic hemodialysis and after renal transplantation: studies in patients without and with systemic amyloidosis. J Am Soc Nephrol 10 (1999) 1972-1981
35. Levy W.C., Cerqueira M.D., Harp G.D., et al. Effect of endurance exercise training on heart rate variability at rest in healthy young and older men. Am J Cardiol 82 (1998) 1236-1241
36. Deligiannis A., Kouidi E., and Tourkantonis A. Effects of physical training on heart rate variability in patients on hemodialysis. Am J Cardiol 84 (1999) 197-202
37. Christensen J.H., Gustenhoff P., Korup E., et al. Effect of fish oil on heart rate variability in survivors of myocardial infarction: a double blind randomised controlled trial. BMJ 312 (1996) 677-678
38. Holguin F., Tellez-Rojo M.M., Lazo M., et al. Cardiac autonomic changes associated with fish oil vs soy oil supplementation in the elderly. Chest 127 (2005) 1102-1107
39. Geelen A., Zock P.L., Swenne C.A., Brouwer I.A., Schouten E.G., and Katan M.B. Effect of n-3 fatty acids on heart rate variability and baroreflex sensitivity in middle-aged subjects. Am Heart J 146 (2003) E4
40. O'Keefe Jr. J.H., Abuissa H., Sastre A., Steinhaus D.M., and Harris W.S. Effects of omega-3 fatty acids on resting heart rate, heart rate recovery after exercise, and heart rate variability in men with healed myocardial infarctions and depressed ejection fractions. Am J Cardiol 97 (2006) 1127-1130
41. Fiedler R., Mall M., Wand C., and Osten B. Short-term administration of omega-3 fatty acids in hemodialysis patients with balanced lipid metabolism. J Ren Nutr 15 (2005) 253-256
42. Geelen A., Brouwer I.A., Schouten E.G., Maan A.C., Katan M.B., and Zock P.L. Effects of n-3 fatty acids from fish on premature ventricular complexes and heart rate in humans. Am J Clin Nutr 81 (2005) 416-420
43. Kannel W.B., Kannel C., Paffenbarger Jr. R.S., and Cupples L.A. Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J 113 (1987) 1489-1494
44. Wannamethee G., Shaper A.G., Macfarlane P.W., and Walker M. Risk factors for sudden cardiac death in middle-aged British men. Circulation 91 (1995) 1749-1756